Let-7 Modulates Chromatin Configuration and Target Gene Repression through Regulation of the ARID3B Complex

Cell Reports

Volumn 14, Issue 3, 2016, Pages 520-533

  Liao, Tsai Tsen ^a   Hsu, Wen Hao ^a   Ho, Chien Hsin ^a   Hwang, Wei Lun ^d   Lan, Hsin Yi ^a   Lo, Ting ^a   Chang, Cheng Chi ^e   Tai, Shyh Kuan ^b   Yang, Muh Hwa ^a,b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEMETHYLASE; HISTONE DEMETHYLASE 4C; KARYOPHERIN; KARYOPHERIN 9; LETHAL 7 MICRORNA; MICRORNA; NUCLEAR PROTEIN; PROTEIN ARID3A; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; ARID3A PROTEIN, HUMAN; ARID3B PROTEIN, HUMAN; CHROMATIN; DNA BINDING PROTEIN; HISTONE; IMPORTIN 9, HUMAN; MIRNLET7 MICRORNA, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INTERACTION; TUMOR INVASION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; CHROMATIN; GENETICS; METABOLISM; MORTALITY; NEOPLASM; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; SEQUENCE ALIGNMENT; XENOGRAFT;

ANIMALS; BASE SEQUENCE; CELL LINE; CHROMATIN; DNA-BINDING PROTEINS; FEMALE; HISTONES; HUMANS; KARYOPHERINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASMS; OCTAMER TRANSCRIPTION FACTOR-3; OLIGONUCLEOTIDES, ANTISENSE; RNA INTERFERENCE; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS; TRANSCRIPTOME; TRANSPLANTATION, HETEROLOGOUS;

EID: 84954305062     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.12.064     Document Type: Article

References (34)

1. Azuara V., Perry P., Sauer S., Spivakov M., Jørgensen H.F., John R.M., Gouti M., Casanova M., Warnes G., Merkenschlager M., Fisher A.G. Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 2006, 8:532-538.
2. Büssing I., Slack F.J., Grosshans H. let-7 microRNAs in development, stem cells and cancer. Trends Mol. Med. 2008, 14:400-409.
3. Chien C.S., Wang M.L., Chu P.Y., Chang Y.L., Liu W.H., Yu C.C., Lan Y.T., Huang P.I., Lee Y.Y., Chen Y.W., et al. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State. Cancer Res. 2015, 75:2553-2565. 10.1158/0008-5472.CAN-14-2215.
4. Dawson M.A., Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012, 150:12-27.
5. Hwang W.L., Jiang J.K., Yang S.H., Huang T.S., Lan H.Y., Teng H.W., Yang C.Y., Tsai Y.P., Lin C.H., Wang H.W., Yang M.H. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat. Cell Biol. 2014, 16:268-280.
6. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
7. Kim D., Tucker P.W. A regulated nucleocytoplasmic shuttle contributes to Bright's function as a transcriptional activator of immunoglobulin genes. Mol. Cell. Biol. 2006, 26:2187-2201.
8. Kim D., Probst L., Das C., Tucker P.W. REKLES is an ARID3-restricted multifunctional domain. J. Biol. Chem. 2007, 282:15768-15777.
9. Kobayashi K., Era T., Takebe A., Jakt L.M., Nishikawa S. ARID3B induces malignant transformation of mouse embryonic fibroblasts and is strongly associated with malignant neuroblastoma. Cancer Res. 2006, 66:8331-8336.
10. Kobayashi K., Jakt L.M., Nishikawa S.I. Epigenetic regulation of the neuroblastoma genes, Arid3b and Mycn. Oncogene 2013, 32:2640-2648.
11. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
12. Marino A.L., Evangelista A.F., Vieira R.A., Macedo T., Kerr L.M., Abrahão-Machado L.F., Longatto-Filho A., Silveira H.C., Marques M.M. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study. BMC Cancer 2014, 14:739.
13. Mayr C., Hemann M.T., Bartel D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007, 315:1576-1579.
14. McDonald O.G., Wu H., Timp W., Doi A., Feinberg A.P. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat. Struct. Mol. Biol. 2011, 18:867-874.
15. Melton C., Judson R.L., Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 2010, 463:621-626.
16. Nachury M.V., Weis K. The direction of transport through the nuclear pore can be inverted. Proc. Natl. Acad. Sci. USA 1999, 96:9622-9627.
17. Numata S., Claudio P.P., Dean C., Giordano A., Croce C.M. Bdp, a new member of a family of DNA-binding proteins, associates with the retinoblastoma gene product. Cancer Res. 1999, 59:3741-3747.
18. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 2007, 104:973-978.
19. Rhee C., Lee B.K., Beck S., Anjum A., Cook K.R., Popowski M., Tucker H.O., Kim J. Arid3a is essential to execution of the first cell fate decision via direct embryonic and extraembryonic transcriptional regulation. Genes Dev. 2014, 28:2219-2232.
20. Roy L., Samyesudhas S.J., Carrasco M., Li J., Joseph S., Dahl R., Cowden Dahl K.D. ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature. Oncotarget 2014, 5:8355-8366.
21. Ruzzo A., Graziano F., Vincenzi B., Canestrari E., Perrone G., Galluccio N., Catalano V., Loupakis F., Rabitti C., Santini D., et al. High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease. Oncologist 2012, 17:823-829.
22. Sampson V.B., Rong N.H., Han J., Yang Q., Aris V., Soteropoulos P., Petrelli N.J., Dunn S.P., Krueger L.J. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 2007, 67:9762-9770.
23. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., Harano T., Yatabe Y., Nagino M., Nimura Y., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004, 64:3753-3756.
24. Tee W.W., Reinberg D. Chromatin features and the epigenetic regulation of pluripotency states in ESCs. Development 2014, 141:2376-2390.
25. Viswanathan S.R., Daley G.Q., Gregory R.I. Selective blockade of microRNA processing by Lin28. Science 2008, 320:97-100.
26. Webb C.F., Bryant J., Popowski M., Allred L., Kim D., Harriss J., Schmidt C., Miner C.A., Rose K., Cheng H.L., et al. The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development. Mol. Cell. Biol. 2011, 31:1041-1053.
27. Wen B., Wu H., Shinkai Y., Irizarry R.A., Feinberg A.P. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat. Genet. 2009, 41:246-250.
28. Wilson B.G., Roberts C.W. SWI/SNF nucleosome remodellers and cancer. Nat. Rev. Cancer 2011, 11:481-492.
29. Wu M.Z., Tsai Y.P., Yang M.H., Huang C.H., Chang S.Y., Chang C.C., Teng S.C., Wu K.J. Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition. Mol. Cell 2011, 43:811-822.
30. Wu C.Y., Tsai Y.P., Wu M.Z., Teng S.C., Wu K.J. Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends Genet. 2012, 28:454-463.
31. Yang M.H., Hsu D.S., Wang H.W., Wang H.J., Lan H.Y., Yang W.H., Huang C.H., Kao S.Y., Tzeng C.H., Tai S.K., et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat. Cell Biol. 2010, 12:982-992.
32. Yang W.H., Lan H.Y., Huang C.H., Tai S.K., Tzeng C.H., Kao S.Y., Wu K.J., Hung M.C., Yang M.H. RAC1 activation mediates Twist1-induced cancer cell migration. Nat. Cell Biol. 2012, 14:366-374.
33. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., Huang Y., Hu X., Su F., Lieberman J., Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007, 131:1109-1123.
34. Zhu J., Adli M., Zou J.Y., Verstappen G., Coyne M., Zhang X., Durham T., Miri M., Deshpande V., De Jager P.L., et al. Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 2013, 152:642-654.